Key points are not available for this paper at this time.
In this analysis, 5 years of treatment with pravastatin was associated with a significant reduction in coronary events for a subsequent 10 years in men with hypercholesterolemia who did not have a history of myocardial infarction.
Ford et al. (Wed,) studied this question.